Skip to main content

RHAPSIDO

Generic: remibrutinib

Verified·Oct 26, 2026
Manufacturer
GlaxoSmithKline
NDC
0078-1483
RxCUI
2724392
Route
ORAL
ICD-10 indication
L50.1

Affordability Check

How much will you actually pay for RHAPSIDO?

In 30 seconds, see every legitimate way to afford RHAPSIDO — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About RHAPSIDO

What is this medication? Voltaren is a prescription topical medication primarily used to relieve the pain of osteoarthritis in joints that can be treated through the skin, such as the knees, hands, wrists, and elbows. It contains diclofenac sodium, which belongs to a group of drugs known as nonsteroidal anti-inflammatory drugs or NSAIDs. By applying the medication directly to the painful area, it targets the source of discomfort to reduce inflammation and swelling specifically in the affected joint. The medication works by stopping the body's production of certain natural substances that cause pain and inflammation. Because it is a topical treatment, a smaller amount of the drug enters the bloodstream compared to oral pain relievers, which may help reduce the risk of certain systemic side effects. It is typically applied several times a day as directed by a healthcare provider, and it is important to avoid applying it to broken or infected skin.

Copay & patient assistance

  • Patient Copay Amount: As little as $0
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Valid only for patients with private insurance. Not valid for patients enrolled in Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program. Not valid where the patient is not using insurance coverage, where the insurance plan reimburses for the entire cost, or where the product is not covered by insurance. Valid only in the United States and Puerto Rico.
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How RHAPSIDO appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

2%

108 of 5,499 plans

Most common tier

Tier 5

On 58% of covering formularies

Prior authorization required

100%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)15
42%
Tier 5 (specialty)21
58%

Step therapy: 0% of formularies

Quantity limits: 100% of formularies

Coverage breadth: 36 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.